Pharmacokinetics of amikacin in plasma and selected body fluids of healthy horses after a single intravenous dose

Equine Veterinary Journal

Volumn 43, Issue 1, 2011, Pages 112-116

  Pinto, N ^a   Schumacher, J ^a   Taintor, J ^a   Degraves, F ^a   Duran, S ^a   Boothe, D ^b  

^a AUBURN UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Amikacin; Horse; Pharmacokinetics

Indexed keywords

AMIKACIN; ANTIINFECTIVE AGENT;

ANIMAL; AREA UNDER THE CURVE; ARTICLE; ASCITES FLUID; BLOOD; CHEMISTRY; DOSE RESPONSE; DRUG ADMINISTRATION; EXTRACELLULAR FLUID; HALF LIFE TIME; HORSE; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM; SYNOVIAL FLUID;

AMIKACIN; ANIMALS; ANTI-BACTERIAL AGENTS; AREA UNDER CURVE; ASCITIC FLUID; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; EXTRACELLULAR FLUID; HALF-LIFE; HORSES; INJECTIONS, INTRAVENOUS; SYNOVIAL FLUID;

EQUIDAE; NEGIBACTERIA;

EID: 78650079175     PISSN: 04251644     EISSN: 20423306     Source Type: Journal    
DOI: 10.1111/j.2042-3306.2010.00144.x     Document Type: Article

References (25)

1. Adamson, P.J., Wilson, W.D., Hirsh, D.C., Baggot, J.D. and Martin, L.D. (1985) Susceptibility of equine bacterial isolates to antimicrobial agents. Am. J. vet. Res. 46, 447-450.
2. Anon (2009) Performance Standards for Antimicrobial Susceptibility Testing: 19th informational supplement. Clinical and Laboratory Standards Institute document M100-S19, 19th ed. Clinical and Laboratory Standards Institute, Wayne.
3. Bartal, C., Danon, A., Schlaeffer, F., Reisenberg, K., Alkan, M., Smoliakov, R., Sidi, A. and Almog, Y. (2003) Pharmacokinetic dosing of aminoglycosides; a controlled trial. Am. J. Med. 114, 194-198.
4. Begg, E.J. and Barclay, M.L. (1995) Aminoglycosides - 50 years on. Br. J. clin. Pharmacol. 39, 597-603.
5. Brown, M.P., Embertson, R.M., Gronwall, R.R., Beal, C., Mayhew, I.G. and Curry, S.H. (1984) Amikacin sulphate in mares: Pharmacokinetics and body fluid and endometrial concentrations after repeated intramuscular administration. Am. J. vet. Res. 45, 1610-1613.
6. Bucki, E.P., Giguère, S., Macpherson, M. and Davis, R. (2004) Pharmacokinetics of once-daily Amikacin in healthy foals and therapeutic drug monitoring in hospitalized equine neonates. J. vet. intern. Med. 18, 728-733.
7. Caron, J.P., Bolin, C.A., Hauptman, J.G. and Johnston, K.A. (2009) Minimum inhibitory concentration and postantibiotic effect of amikacin for equine isolates of methicillin-resistant Staphylococcus aureus in vitro. Vet. Surg. 38, 664-669.
8. Contopoulos-Ioannidis, D.G., Giotis, N.D., Baliatsa, D.V. and Ioannidis, J.P. (2004) Extended-interval aminoglycoside administration for children: A meta-analysis. Pediatrics 11, 111-118.
9. Cummings, L.E., Guthrie, A.J., Harkins, J.D. and Short, C.R. (1985) Pharmacokinetics of gentamicin in newborn to 30-day-old foals. Am. J. vet. Res. 51, 1988-1992.
10. Fisman, D.N. and Kaye, K.M. (2000) Once-daily dosing of aminoglycoside antibiotics. Infect. Dis. Clin. N. Am. 14, 475-487.
11. Golenz, M.R., Wilson, W.D., Carlson, G.P., Craychee, T.J., Mihalyi, J.E. and Knox, L. (1994) Effect of route of administration and age on the pharmacokinetics of Amikacin administered by the intravenous and intraosseous routes to 3- and 5-day-old foals. Equine vet. J. 26, 367-373.
12. Horspool, J.L., Taylor, D.J. and Mckellar, O.A. (1994) Plasma disposition of Amikacin and interactions with gastrointestinal microflora in Equidae following intravenous and oral administration. J. vet. Pharmacol. Ther. 17, 291-298.
13. Jacks, S.S., Giguere, S. and Nguyen, A. (2003) In vitro susceptibilities of Rhodoccocus equi and other common equine pathogens to azitromycin, clarithromycin, and other 20 other antimicrobials. Antimicrob. Agents Chemother. 47, 1742-1745.
14. Kashuba, A.D., Bertino, J.S. Jr and Nafziger, A.N. (1998) Dosing of aminoglycosides to rapidly attain pharmacodynamic goals and hasten therapeutic response by using individualized pharmacokinetic monitoring of patients with pneumonia caused by Gram-negative organisms. Antimicrob. Agents Chemother. 42, 1842-1844.
15. Lacy, M.K., Nicolau, D.P., Nightingale, C.H. and Quintiliani, R. (1998) The pharmacodynamics of aminoglycosides. Clin. Infect. Dis. 27, 23-27.
16. McKenzie, H.C. and Furr, M.O. (2003) Aminoglycoside antibiotics in neonatal foals. Compendium Equine 25, 457-469.
17. McKinnon, P.S. and Davis, S.L. (2004) Pharmacokinetic and pharmacodynamic issues in the treatment of bacterial infectious diseases. Eur. J. Clin. Microbiol. 23, 271-288.
18. Magdesian, K.G., Wilson, W.D. and Mihalyi, J. (2004) Pharmacokinetics of a high dose of amikacin administered at extended intervals to neonatal foals. Am. J. vet. Res. 65, 473-479.
19. Moore, R.D., Smith, C.R. and Lietman, P.S. (1984) The association of aminoglycoside plasma levels with mortality in patients with Gram-negative bacteremia. J. Infect. Dis. 149, 443-448.
20. Moore, R.D., Smith, C.R. and Litman, P.S. (1987) Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration. J. Infect. Dis. 155, 93-99.
21. Nagai, J. and Takano, M. (2004) Molecular aspects of renal handling of aminoglycosides and strategies for preventing the nephrotoxicity. Drug Metab. Pharmacok. 19, 159-170.
22. Orsini, J.A., Soma, L.R., Rourke, J.E. and Park, M. (1985) Pharmacokinetics of amikacin in the horse following intravenous and intramuscular administration. J. vet. Pharmacol. Ther. 8, 194-201.
23. Renneberg, J. and Walder, M. (1989) Postantibiotic effects of imipenem, norfloxacin, and amikacin in vitro and in vivo. Antimicrob. Agents Chemother. 33, 1714-1720.
24. Rougier, F., Claude, D., Maurin, M. and Maire, P. (2004) Aminoglycoside nephrotoxicity. Curr. Drug Targets Infect. Disord. 4, 153-162.
25. Sojka, J.E. and Brown, S.A. (1986) Pharmacokinetic adjustment of gentamicin dosing in horses with sepsis. J. Am. vet. med. Ass. 189, 784-789.